Table 3 All-Cause healthcare resource utilization during the follow-up period
Patients with T2D | Patients with CVD | |||||
|---|---|---|---|---|---|---|
With comorbid MDD (n = 11,446) | Without comorbid MDD (n = 11,446) | P value | With comorbid MDD (n = 14,149) | Without comorbid MDD (n = 14,149) | P value | |
Average follow-up time, months | ||||||
Mean (SD) | 33.1 (16.7) | 32.0 (16.2) | < 0.0001 | 29.7 (14.0) | 29.2 (13.8) | 0.0016 |
Proportion of patients requiring, n (%): | ||||||
Hospitalizations | 2989 (26.1) | 1986 (17.4) | < 0.0001 | 6419 (45.4) | 4826 (34.1) | < 0.0001 |
ED visits | 6328 (55.3) | 4918 (43.0) | < 0.0001 | 9411 (66.5) | 7832 (55.4) | < 0.0001 |
Outpatient visits | 11,443 (100.0) | 11,429 (99.9) | 0.0025 | 14,146 (100.0) | 14,144 (100.0) | 0.73 |
Hospitalizations per patient | ||||||
Mean (SD) | 0.3 (0.8) | 0.1 (0.4) | < 0.0001 | 0.5 (1.2) | 0.3 (0.8) | < 0.0001 |
Length of stay, days | ||||||
Mean (SD) | 1.6 (7.6) | 0.7 (3.3) | < 0.0001 | 3.6 (11.3) | 1.8 (6.4) | < 0.0001 |
ED visits per patient | ||||||
Mean (SD) | 0.9 (2.5) | 0.6 (1.9) | < 0.0001 | 1.3 (2.8) | 0.9 (2.8) | < 0.0001 |
Laboratory visits per patient | ||||||
Mean (SD) | 3.9 (5.0) | 3.2 (3.8) | < 0.0001 | 4.5 (5.6) | 3.7 (4.9) | < 0.0001 |
Outpatient visits per patient | ||||||
Mean (SD) | 21.4 (18.6) | 14.4 (13.8) | < 0.0001 | 26.5 (21.3) | 18.5 (16.5) | < 0.0001 |
Primary care visits | ||||||
Mean (SD) | 4.9 (4.2) | 4.1 (4.0) | < 0.0001 | 5.0 (4.6) | 4.0 (4.1) | < 0.0001 |
Psychiatrist visits | ||||||
Mean (SD) | 1.1 (3.1) | 0.1 (1.1) | < 0.0001 | 1.2 (3.5) | 0.1 (0.9) | < 0.0001 |
Behavioral therapy visits | ||||||
Mean (SD) | 3.3 (8.9) | 0.5 (3.0) | < 0.0001 | 3.6 (8.8) | 0.6 (3.8) | < 0.0001 |
Prescriptions per patient | ||||||
Mean (SD) | 6.1 (7.8) | 4.4 (6.0) | < 0.0001 | 7.4 (8.6) | 5.2 (6.5) | < 0.0001 |